Ardent Health Reports Q3 Results, Raises 2026 EBITDA Guidance
Ardent Health reported $1.625 billion in third-quarter revenue, up 3.1% year over year, and net income of $45 million versus a $23.5 million loss a year earlier. It raised full-year adjusted EBITDA guidance to $500 million–$535 million, increased its share repurchase program by $25 million and agreed to transfer full ownership of its Kansas hospital to its joint venture partner.
Ardent Health, Inc. announced its financial results for the third quarter of 2026, reporting revenue of $1.625 billion, a 3.1% increase year over year. The company achieved net income of $45 million, compared to a net loss of $23.5 million in the same period last year, with adjusted EBITDA reaching $138 million. Driven by improved volume trends, including a 2.9% increase in adjusted admissions, the company raised the midpoint of its full-year 2026 adjusted EBITDA guidance to a range of $500 million to $535 million.
Additionally, Ardent Health announced a $25 million increase to its share repurchase program and entered into a definitive agreement to transition full ownership of its Kansas hospital to its joint venture partner. The company also noted a reduction in its capital expenditure guidance for the year.